Latest Post

The Top Ingredients to Look For in Menopausal Skin-Care Probiotics: Solving Poor Digestive Health How to Do Double Leg Lift in Pilates? Tips, Technique, Correct Form, Benefits and Common Mistakes Top 5 Emerging Skincare Markets in 2022: Brazil, China, India, Mexico and South Africa – Market Summary, Competitive Analysis and Forecast to 2025 – ResearchAndMarkets.com Kelvin Harrison Jr. Is Growing with the Flow

Pharmacists are urgent thousands of Kiwis living with asthma to use preventative medication for the chronic disease every day – prior to exposure to COVID.

The call comes following analysis of discussions with hundreds of COVID positive patients over the past week, which found a number of those with pre-existing respiratory conditions such as asthma or Chronic Obstructive Pulmonary Disease (COPD) are struggling with the impact of contracting Omicron.

New Zealand has a high prevalence of asthma, with one in eight (12%) adults having been prescribed asthma medication. Up to 15% of the population are believed to be affected by COPD. NZ also has one of the highest hospital admission rates for asthma of all OECD countries.[1]

Adherence to prescription medicine is also a significant issue for the country with research finding a third (33%) of Kiwis have had a doctor’s prescription which they have not filled.[2]

Din Redzepagic, pharmacist at Zoom Pharmacy, says his team have interviewed hundreds of COVID positive patients as part of a new DHB program to deliver free medicines to those isolating.

Din Redzepagic

He says the health care intervention model developed by the DHB requires pharmacists to have a virtual consultation with COVID to understand how well they are managing.

“The new DHB initiative means pharmacists are now talking with a large sample of patients who have COVID and it is giving us unique insights into how those with other chronic conditions are managing with the symptoms of the new virus.

“What we know about the current surge in Omicron cases is that around one in every twenty patients we are talking to are getting very sick.

“There are obvious signs of severe respiratory distress among many of them and further analysis reveals that many have been diagnosed with asthma, but are not regularly using their preventative inhaler.

“It is concerning to see that some of those already living with respiratory diseases such as asthma and COPD have let their management plans lapse and are not adhering to their doctor’s advice on the frequency of using a preventer.

“As a result we have advised three of the patients isolating with significant breathing difficulty in the last two days to call an ambulance,” he says.

Redzepagic says the preventer is designed to deliver medicine into the respiratory system, preventing symptoms and reducing the potential for asthma attacks.

He says the trend is particularly noticeable in areas with traditionally poor access to health care services but higher concentrations of COVID positive patients – such as South and West Auckland.

“What we may be seeing at the moment is a combination of two aspects of healthcare which are relatively unique to New Zealand – our unusually high prevalence of asthma and high rates of Maori and Pasifika with pre-existing respiratory diseases who are also testing positive for COVID.

“In addition to ensuring they have had all three doses of the vaccine, it is important that those with pre-existing respiratory conditions such as asthma take a number of additional steps to prepare for the possibility of a COVID infection.

“The first thing to do is to check their stocks of preventer inhalers – including their expiry date, if they have lapsed in taking the medicine every day they need to restart this according to the advice given to them by their HCP.

“This is important as they may be out of practice with timing their breathing with delivery of medicine through the inhaler.

“This inhaler should be used every day as it may take two to four weeks before it reaches its full effect.

“They should then look at talking to their GP about how well their asthma is being managed – this may require using a peak flow meter which can be done at home as part of a virtual consultation,” he says.

Redzepagic says Zoom Pharmacy are expanding capacity to cope with the growing demand from patients required to isolate at home.

He says they now have a team of motorcyclists who can more easily navigate peak hour traffic – to ensure same day deliveries to patients in need.

“The level of demand at the moment from the thousands of patients which are isolating is so high, that our morning shift is starting at 3am.

“In the past two days we have delivered over 750 medicine packs and we expect this number to grow significantly over the coming weeks,” he says.

[1]https://www.hqsc.govt.nz/our-data/atlas-of-healthcare-variation/asthma/

[2]

Zoom Pharmacy research.

© Scoop Media

.

Leave a Reply

Your email address will not be published.

%d bloggers like this: